Distribution of secreted aspartyl proteinases using a polymerase chain reaction assay with SAP specific primers in Candida albicans isolates
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články
PubMed
16475500
DOI
10.1007/bf02931422
Knihovny.cz E-zdroje
- MeSH
- aspartátové endopeptidasy analýza genetika MeSH
- Candida albicans enzymologie genetika izolace a purifikace MeSH
- DNA fungální analýza MeSH
- fungální proteiny analýza genetika MeSH
- geny hub MeSH
- izoenzymy antagonisté a inhibitory genetika MeSH
- kandidóza mikrobiologie MeSH
- krev mikrobiologie MeSH
- lidé MeSH
- polymerázová řetězová reakce metody MeSH
- vagina mikrobiologie MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- aspartátové endopeptidasy MeSH
- DNA fungální MeSH
- fungální proteiny MeSH
- izoenzymy MeSH
- SAP1 protein, Candida albicans MeSH Prohlížeč
- SAP2 protein, Candida MeSH Prohlížeč
- SAP3 protein, Candida albicans MeSH Prohlížeč
- SAP4 protein, Candida albicans MeSH Prohlížeč
- SAP5 protein, Candida albicans MeSH Prohlížeč
Secreted aspartyl proteinase (Sap) distribution among different C. albicans isolates was determined using SAP-specific primers in polymerase chain reaction (PCR) assay. SAP1, SAP2, and SAP3 were detected in 13 of 40 (32.5%), SAP4 in 38/40 (95%), SAP5 were detected in 30/40 (75%), SAP6 in 23/40 (57.5%) of C. albicans strains isolated from blood cultures. SAP1-SAP3 were detected in 37 of 40 (92.5%), SAP4 were detected in 3/40 (7.5%), SAP5 in 3/40 (7.5%), SAP6 in 5/40 (12.5%) of C. albicans strains isolated from vaginal swab cultures. Sap1, Sap2 and Sap3 isoenzymes were found to be related to the vaginopathic potential of C. albicans; Sap4, Sap5 and Sap6 isoenzymes were found to be correlated with systemic infections.
Zobrazit více v PubMed
Folia Microbiol (Praha). 2004;49(4):491-6 PubMed
Folia Microbiol (Praha). 2004;49(5):527-33 PubMed
J Clin Microbiol. 1998 Feb;36(2):395-401 PubMed
J Clin Microbiol. 1994 Jan;32(1):228-31 PubMed
J Invest Dermatol. 2000 Apr;114(4):712-7 PubMed
Infect Immun. 2002 Jul;70(7):3689-700 PubMed
Microbiology (Reading). 2001 Aug;147(Pt 8):1997-2005 PubMed
Folia Microbiol (Praha). 2003;48(2):173-6 PubMed
Infect Immun. 1997 Feb;65(2):551-6 PubMed
Biochim Biophys Acta. 2000 Jul 14;1480(1-2):117-31 PubMed
J Clin Microbiol. 2003 Feb;41(2):712-6 PubMed
Infect Immun. 1997 Sep;65(9):3529-38 PubMed
Mycoses. 1996 Sep-Oct;39(9-10):347-51 PubMed
Infect Immun. 1997 Sep;65(9):3539-46 PubMed
Folia Microbiol (Praha). 2003;48(2):203-9 PubMed
J Infect Dis. 1999 Jan;179(1):201-8 PubMed
J Med Microbiol. 2001 Aug;50(8):743-747 PubMed
Antimicrob Agents Chemother. 2000 May;44(5):1200-8 PubMed
Sabouraudia. 1970 Nov;8(3):189-200 PubMed
Clin Diagn Lab Immunol. 1999 Nov;6(6):924-9 PubMed
Proc Natl Acad Sci U S A. 2000 May 23;97(11):6102-7 PubMed
Clin Microbiol Rev. 1996 Oct;9(4):469-88 PubMed
J Infect Dis. 1987 Nov;156(5):777-83 PubMed
Infect Immun. 1999 May;67(5):2482-90 PubMed
Med Mycol. 2001 Aug;39(4):303-13 PubMed
Candidiasis--do we need to fight or to tolerate the Candida fungus?
